J Chen, B Yin, W Wang, H Sun - ACS Chemical Neuroscience, 2020 - ACS Publications
The β-amyloid cleaving enzyme 1 (BACE1) has been thought to be an efficient target for
treatment of Alzheimer's disease (AD). Deep insight into inhibitor–BACE1 binding …